Global qPCR and dPCR Instrumentation Market Report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
38
Global qPCR and dPCR Instrumentation Market Report 2016-2019 & 2024: Increasing Incidence and Prevalence of Cancer - A Grim Reality Driving Demand for qPCR and dPCR

Dublin, Feb. 07, 2019 (GLOBE NEWSWIRE) -- The "qPCR and dPCR Instrumentation - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousand by the following Product Categories:

  • Reagents
  • Instruments

Also, the report analyzes the Global market by the following Product Categories, Product Segments, and End-Use Segments:

  • Product Categories - Reagents, Instruments
  • Product Segments - qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction)
  • End-Use Segments - Educational/Research, Testing Laboratories, and Pharma.

The report profiles 36 companies including many key and niche players such as:

  • Agilent Technologies, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • BioFire Diagnostics, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cepheid (USA)
  • Eppendorf AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fluidigm Corporation (USA)
  • Promega Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • RainDance Technologies, Inc. (USA)
  • Takara Bio, Inc. (Japan)
  • Thermo Fisher Scientific Inc. (USA)

Key Topics Covered:

1. INDUSTRY OVERVIEW Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification Sizing the Market Developing Countries Exude Tremendous Potential for Growth qPCR Remains the Mainstay Technology Research and Testing Major Application Markets Striking the Right Balance between qPCR and Dpcr in Research Laboratories qPCR- A Suitable Tool for Gene Expression and Validation A Peek into Select qPCR Systems Available in Marketplace Thermo Fisher Life Sciences Prism 7000 Series Thermo Fisher Life Sciences ViiA 7 Thermo Fisher Life Sciences QuantStudio Cepheid SmartCycler Platform Roche LightCycler Platform Roche FLOW As qPCR Technology Matures, Saturation is Imminent Digital PCR to Take Quantification of Nucleic Acids to the Next Level dPCR A Valuable Tool in Virology Research High Sensitivity in Viral Detection Creation and Validation of Viral Reference Standards High-Precision Quantification Sales of Digital PCR to Skyrocket in the Near Term dPCR Holds Potential to Capture Application Markets from Predecessor Technologies New dPCR Systems to Capture a Bigger Slice of the Market QuantStudio 3D Digital PCR System QuantStudio 12K BioMark HD system QX100 droplet digital PCR System RainDrop Systems High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR Despite Onslaught of Digital PCR, qPCR Maintains Relevance 2. GROWTH DRIVERS, MARKET TRENDS & ISSUES Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter Growing Prevalence of Genetic Disorders and Infectious Diseases Provide a Strong Case for Growth Innovations in Instrumentation Expand Functionality and Drive Adoption Adaptive PCR A Recent Advancement Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies qPCR and NGS to Drive Single-Cell Genomics Market Advancements in Probe Technology Enhance qPCR Sensitivity qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment Factors influencing Selection of Lab Robots Lab on Chip/Microfluidic Real-time-PCR A Game Changer in the Offing Two Types of Microfluidic Designs Advantages of Lab on Chip PCR Roadblocks in the Path to Development New Developments in Lab-on-chip PCR dPCR for Liquid Biopsies Areas of Digital PCR has Immense Potential ddPCR The More Advanced Digital Approach to dPCR Droplet digital PCR Finds Increasing Application in Life Sciences Research ddPCR Gains Traction in Cancer Diagnosis Monitoring Disease Progression in HIV Studies Analysis of Genetically Modified Organisms in Edible Products RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples Adoption of High Throughput Platforms Gains Pace MC-ICP, A New Technique for Increasing Sensitivity of dPCR Instruments Study Establishes High Reproducibility of dPCR Clarity dPCR An Advanced dPCR for Improved Workflows Veterinary Diagnostic Applications Yet to Embrace dPCR Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines Alternate Technologies Pose Threat to Growth of PCR Market New Isothermal PCR Technology A Potential Game Changer Promising Faster PCR 3. COMPETITIVE LANDSCAPE qPCR A Highly Concentrated Market Place Select qPCR Products by Company Cost of PCR instruments and Reagents to Come Under Pressure Competitive Landscape of dPCR Market Bio-Rad Makes Rapid Strides in Life Science Arena with Two Big Deals Qiagen Strengthens its Hold with Acquisitions Intense Competition Triggers a Spate of M&A Multiple Factors to Sustain Consolidation Trend in PCR Industry Accelerated Commercialization of Products Offering Integrated and Multi-technology Solutions Manufacturers Step-Up Online Exposure Manufacturers Target Expansion of Distribution Reach and Global Footprint 4. END-USE MARKET ANALYSIS Application Areas of PCR Medical and Diagnostics PCR Plays a Vital Role in the Diagnosis of Infectious Diseases Detection of Antimicrobial Resistance PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents Forensic and Paternity Testing Food Safety Detection and Quantification of Food Pathogens Detection of Beneficial and Non-Pathogenic Microbes Study of Microbial Responses to Environment Microbial Risk Assessment qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate PCR Technique in Identification of GMOs Research & Academics SYBR Dye and TaqMan Techniques Popular in Research Publications 5. PRODUCT OVERVIEW Introduction to Polymerase Chain Reaction (PCR) Reagents and Components Required for PCR Reaction Steps Denaturation Annealing Extension Real-Time PCR or Quantitative PCR (qPCR) qPCR Instrumentation Evolution Working of qPCR Instruments Thermal Control Fluorimetry DNA Detection Methods Fluorescence Measurement Asymmetrical dsDNA dyes Quantification High-Throughput qPCR Comparison of Working of Conventional PCR versus qPCR Drawbacks in Core PCR Advantages of qPCR Disadvantages of qPCR End-Use Applications of qPCR Factors Influencing Purchase Decisions of qPCR Systems qPCR Consumables, Accessories and Software DIGITAL PCR Development of dPCR Working Principle Droplet dPCR Applications of dPCR Advantages of dPCR 6. PRODUCT INNOVATIONS/INTRODUCTIONS Bio-Rad Rolls Out New RT-PCR Kit for Simultaneous Screening of Various Viruses Agilent Technologies Launches AriaDx Real-Time PCR System FORMULATRIX Introduces CONSTELLATION Digital PCR System Roche Rolls Out cobas Liat PCR System in Europe Thermo Fisher Launches QuantStudio 5 RT PCR System RainDance Introduces RainDrop Plus Digital PCR System Stilla Launches Digital PCR System Analytik Jena Unveils qTOWER RT PCR Thermal Cycler Bio-Rad Rolls Out ddPCR Supermix Takara Bio Unveils Thermal Cycler Dice Real Time System III Exiqon Introduces ExiLERATE LNA qPCR Reagents and Kits Thermo Fisher Launches PowerUp SYBR Green PCR Master Mix Thermo Fisher Introduces QuantStudio 3 and QuantStudio 5 RT PCR Systems Kapa Biosystems Rolls Out KAPA PROBE FORCE qPCR Kit Agilent Technologies Launches AriaMx System 7. RECENT INDUSTRY ACTIVITY RainDance and Bio-Rad Ink Definitive Acquisition Agreement Curetis Buys Gyronimo Platform from Carpegen and Systec QIAGEN Takes Over Exiqon LGC Takes Over Douglas Scientific Bio-Rad Secures CE Marking for QX200 Droplet Digital PCR System Roche to Take Over Kapa Biosystems LGC to Acquire Biosearch Thermo Fisher Scientific Completes Take Over of Life Technologies 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 36 (including Divisions/Subsidiaries 38)

  • The United States (22)
  • Canada (1)
  • Japan (1)
  • Europe (13)
    • France (1)
    • Germany (5)
    • The United Kingdom (1)
    • Rest of Europe (6)
  • Asia-Pacific (Excluding Japan) (1)

For more information about this report visit https://www.researchandmarkets.com/research/2...r_and?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Molecular Diagnostics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Thor Equities Sells Amazon Distribution Center for $157M

Updated Category News Views 191

Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...

Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand

Updated Category News Views 169

Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...

Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth

Updated Category News Views 341

Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....

Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights

Updated Category News Views 175

Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....

Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation

Updated Category News Views 181

Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...

Continue Reading